What are people with Sjogren's syndrome at risk of developing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risks Associated with Sjögren's Syndrome

Patients with Sjögren's syndrome are at significantly increased risk of developing non-Hodgkin lymphoma (10-44 times higher risk than the general population), particularly marginal zone B-cell lymphomas affecting the salivary glands. 1

Major Complications and Risks

Lymphoproliferative Disorders

  • Non-Hodgkin Lymphoma (NHL)
    • Most serious complication with 10-44 fold increased risk compared to healthy individuals 1
    • Predominantly low-grade B-cell lymphomas of marginal zone histological type 1
    • Primary extranodal involvement of major salivary glands, especially parotid 1
    • Diffuse large B-cell lymphoma is the most common NHL subtype 2
    • Risk factors include presence of cryoglobulinemia and higher EULAR Sjögren's syndrome disease activity index 1

Organ-Specific Complications

  • Oral/Dental Complications

    • Dental decay and oral infections 3
    • Gum inflammation and mouth sores 3
    • Cracked or chipped teeth 3
  • Ocular Complications

    • Eye damage and vision problems 3
    • Corneal ulceration and scarring (from severe dry eye) 3
  • Pulmonary Manifestations

    • Interstitial lung disease 3
    • Chronic dry cough 3
  • Renal Complications

    • Tubulointerstitial nephritis 3
    • Renal tubular acidosis 3
  • Neurological Complications

    • Peripheral neuropathy (numbness or tingling in extremities) 3
    • Autonomic neuropathy 3

Other Associated Conditions

  • Thyroid Cancer

    • Increased risk compared to general population 4
  • Multiple Myeloma

    • Higher incidence in Sjögren's patients 4
  • Skin Cancers

    • Elevated risk reported in some studies 4
  • Other Autoimmune Conditions

    • Increased risk of developing other autoimmune disorders 5
    • Particularly systemic lupus erythematosus and rheumatoid arthritis 5

Risk Stratification and Monitoring

High-Risk Factors for Lymphoma Development

  • Presence of cryoglobulinemia 1
  • Elevated disease activity (high EULAR Sjögren's syndrome disease activity index) 1
  • Salivary gland enlargement 3
  • Persistent parotid enlargement 3

Protective Factors

  • Salivary gland biopsies appear to be associated with lower lymphoma risk 2
  • Immunomodulator therapy (hydroxychloroquine, azathioprine, cyclosporine, methotrexate, rituximab) may reduce lymphoma risk 2

Recommended Monitoring

  • Regular monitoring for lymphoproliferative disorders 3
  • Pulmonary function tests for respiratory complications 3
  • Vigilance for vasculitic manifestations 3
  • Thyroid function monitoring 3
  • In pregnant women with anti-Ro antibodies, fetal echocardiography between 16-26 weeks to monitor for congenital heart block 3

Clinical Pearls

  • The risk of lymphoma in Sjögren's syndrome exceeds that seen in other autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis 1
  • Some lymphomas in Sjögren's syndrome may evolve slowly or even regress spontaneously 6
  • Multiple risk factors in an individual correlate with higher lymphoma risk 1
  • Co-management with a rheumatologist is essential due to potential systemic complications 3

References

Guideline

Sjögren's Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sjögren Syndrome and Cancer.

Rheumatic diseases clinics of North America, 2020

Research

Lymphoma in Sjogren's syndrome.

Medical and pediatric oncology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.